<DOC>
	<DOC>NCT00488176</DOC>
	<brief_summary>The aim of this study is to compare the effect of montelukast and cetirizine on allergic inflammation measured by exhaled nitric oxide concentration in children with seasonal allergic rhinitis.</brief_summary>
	<brief_title>Comparison of the Effect of Montelukast and Cetirizine on Allergic Inflammation in Children With Allergic Rhinitis</brief_title>
	<detailed_description>During the pollen season children with seasonal allergic rhinitis without concomitant asthma are at risk of having allergic inflammation in the lower respiratory tract. About 60% of children with seasonal allergic rhinitis present bronchial hyperresponsiveness and signs and symptoms of asthma. The aim of this study is to compare the effect of montelukast and cetirizine on allergic inflammation measured by exhaled nitric oxide concentration in children with seasonal allergic rhinitis.</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Rhinitis, Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis, Allergic, Seasonal</mesh_term>
	<mesh_term>Cetirizine</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>clinical symptoms of seasonal allergic rhinitis during last two seasons, moderate and severe according to ARIA guidelines diagnosis of bronchial asthma allergy to perennial allergens specific immunotherapy other chronic diseases tobacco smoking acute respiratory tract infection excluded drugs: inhaled and systemic glucocorticosteroids</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>seasonal allergic rhinitis</keyword>
	<keyword>children</keyword>
	<keyword>montelukast</keyword>
	<keyword>cetirizine</keyword>
</DOC>